Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI

BACKGROUND: The purpose of this study was to assess the impact of bevacizumab alone and in combination with cytotoxic therapy on tumour vasculature in osteosarcoma (OS) using DCE-MRI. METHODS: Six DCE-MRI and three (18)F-FDG PET examinations were scheduled in 42 subjects with newly diagnosed OS to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, J, Glass, J O, McCarville, M B, Shulkin, B L, Daryani, V M, Stewart, C F, Wu, J, Mao, S, Dwek, J R, Fayad, L M, Madewell, J E, Navid, F, Daw, N C, Reddick, W E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815789/
https://www.ncbi.nlm.nih.gov/pubmed/26461056
http://dx.doi.org/10.1038/bjc.2015.351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815789/
https://www.ncbi.nlm.nih.gov/pubmed/26461056
http://dx.doi.org/10.1038/bjc.2015.351

Ejemplares similares